Efficacy and Tolerability of Pharmacotherapies for Borderline Personality Disorder

Author： Bellino Silvio Paradiso Erika Bogetto Filippo

ISSN： 1172-7047

Source： CNS Drugs, Vol.22, Iss.8, 2008-01, pp. : 671-692

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy and Tolerability of Pharmacotherapies for Attention-Deficit Hyperactivity Disorder in Adults

By Santosh Paramala J. Sattar Sanjida

CNS Drugs, Vol. 25, Iss. 9, 2011-09 ,pp. : 737-763

Adis International

Access to resources Recommend Favorite

Efficacy and Tolerability of Pharmacotherapies to Aid Smoking Cessation in Adolescents

By Bailey Steffani R.

Pediatric Drugs, Vol. 14, Iss. 2, 2012-04 ,pp. : 91-108

Adis International

Access to resources Recommend Favorite

Opioid addiction and borderline personality disorder

American Journal on Addictions, Vol. 27, Iss. 1, 2018-01 ,pp. : 54-55

John Wiley & Sons Inc

Access to resources Recommend Favorite

Fluvoxamine improves affect lability in borderline personality disorder

Inpharma, Vol. 1, Iss. 1373, 2003-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite

Olanzapine vs Aripiprazole in the Management of Borderline Personality Disorder

By S. Shafti Saeed Kaviani Hamid

Current Psychopharmacology, Vol. 3, Iss. 2, 2014-08 ,pp. : 132-136

Bentham Science Publishers

Access to resources Recommend Favorite